Showing 38,141 - 38,160 results of 106,371 for search '(( 100 g decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.79s Refine Results
  1. 38141
  2. 38142

    Image_3_Effect of Smoking on Lung Function Decline in a Retrospective Study of a Health Examination Population in Chinese Males.TIF by Ting Tian (491224)

    Published 2023
    “…Objective:<p>China has established a goal of reducing adult smoking prevalence from 27.7% to 20% by 2030. …”
  3. 38143

    Data_Sheet_2_Efficacy of a Single Dose of Pregabalin on Signs of Anxiety in Cats During Transportation—A Pilot Study.PDF by Terttu Lamminen (11369739)

    Published 2021
    “…The cats were assigned to receive pregabalin oral solution at dosages of 5 and 10 mg/kg and placebo in a randomized order, one treatment per week. …”
  4. 38144

    Image_2_Effect of Smoking on Lung Function Decline in a Retrospective Study of a Health Examination Population in Chinese Males.TIFF by Ting Tian (491224)

    Published 2023
    “…Objective:<p>China has established a goal of reducing adult smoking prevalence from 27.7% to 20% by 2030. …”
  5. 38145

    Image_1_Effect of Smoking on Lung Function Decline in a Retrospective Study of a Health Examination Population in Chinese Males.TIFF by Ting Tian (491224)

    Published 2023
    “…Objective:<p>China has established a goal of reducing adult smoking prevalence from 27.7% to 20% by 2030. …”
  6. 38146

    DataSheet1_Experimental Investigation of a Novel Formulation of a Cyanoacrylate-Based Adhesive for Self-Healing Concrete Technologies.docx by Cristina De Nardi (10931184)

    Published 2021
    “…When encapsulated within 3D printed mini-vascular networks (MVNs), the n-CAs remained dormant in liquid form for up to 5 days. The contact angle between the n-CAs and the cement mortar substrate, as measured via the sessile drop technique, decreased significantly with increasing AA content. …”
  7. 38147

    Data_Sheet_1_Efficacy of a Single Dose of Pregabalin on Signs of Anxiety in Cats During Transportation—A Pilot Study.PDF by Terttu Lamminen (11369739)

    Published 2021
    “…The cats were assigned to receive pregabalin oral solution at dosages of 5 and 10 mg/kg and placebo in a randomized order, one treatment per week. …”
  8. 38148

    Image_4_Effect of Smoking on Lung Function Decline in a Retrospective Study of a Health Examination Population in Chinese Males.TIFF by Ting Tian (491224)

    Published 2023
    “…Objective:<p>China has established a goal of reducing adult smoking prevalence from 27.7% to 20% by 2030. …”
  9. 38149
  10. 38150

    Products and Mechanism of Acene Dimerization. A Computational Study by Sanjio S. Zade (1567213)

    Published 2011
    “…A concerted asynchronous reaction mechanism was found for benzene and naphthalene dimerization, while a stepwise biradical mechanism was predicted for the dimerization of anthracene, pentacene, and heptacene. …”
  11. 38151

    KChIP2 knock down attenuates <i>I</i><sub><i>Na</i></sub> density. by Drew M. Nassal (845780)

    Published 2016
    “…Right panel shows the average fold change from KChIP2 KD treated cardiomyocytes from control, which resulted in significantly decreased expression following KChIP2 KD (n = 3). Data presented as mean ± SEM; <i>*P</i> < 0.05 two-tailed Student’s <i>t</i>-test performed for I/V plot, paired two-tailed Student’s <i>t</i>-test performed for Western blot.…”
  12. 38152

    Change of <i>SPDEF</i>, <i>MUC5AC</i>, and <i>MUC16</i> mRNA expression levels at follow-up points after rebamipide instillation treatment in SS-DE patients. by Jun Shoji (724385)

    Published 2020
    “…<p>Least-square means (LS means ± 95% confidence interval) ware plotted for relative expression levels of <i>SPDEF</i>, <i>MUC5AC</i>, and <i>MUC16</i> mRNA at each observation point. …”
  13. 38153

    Manipulating the CeA-VTA-ACC/OFC projections. by Karolina Rojek-Sito (13197192)

    Published 2023
    “…<b>(F)</b> Activity after CeA-VTA inhibition. Ctrl: NaCl/c21 <i>n =</i> 5/5, CeA-VTA: NaCl/c21 <i>n</i> = 5/5. …”
  14. 38154

    Image_4_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”
  15. 38155

    Image_7_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”
  16. 38156

    Table_2_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”
  17. 38157

    Table_3_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”
  18. 38158

    Image_2_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”
  19. 38159

    Image_1_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”
  20. 38160

    Image_6_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

    Published 2022
    “…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”